导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -9.94% | 3742/4773 |
| 近一周 | -1.94% | 925/5462 |
| 近一月 | -0.55% | 789/5421 |
| 近一季 | 4.22% | 321/5209 |
| 近半年 | -7.59% | 3239/4920 |
| 近一年 | -13.41% | 3605/4366 |
| 近两年 | 9.44% | 2811/2954 |
| 近三年 | -6.89% | 2002/2253 |
| 成立以来 | 23.08% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.50% 3851/4961 |
-12.59% 4419/5312 |
- - |
- - |
| 2025 | 0.99% 3237/4813 |
0.42% 1858/3635 |
-3.33% 3426/4076 |
5.73% 3567/4524 |
-1.61% 2974/4813 |
| 2024 | 8.70% 1525/3463 |
5.25% 385/2808 |
-4.94% 1593/3014 |
15.40% 1724/3129 |
-5.85% 2599/3463 |
| 2023 | -14.21% 1590/2656 |
2.24% 1396/2280 |
-9.79% 2069/2385 |
-2.17% 632/2515 |
-4.93% 1212/2655 |
| 2022 | -15.31% 416/2207 |
-18.73% 1384/1919 |
16.66% 145/2016 |
-11.53% 541/2113 |
0.96% 1415/2208 |
| 2021 | -11.91% 1117/1822 |
-3.89% 832/1255 |
- 1117/1330 |
-11.80% 1277/1466 |
3.92% 383/1822 |
| 2020 | - - |
- - |
- - |
16.58% 146/1164 |
22.52% 42/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 富国中证消费50ETF联接A VS. 长安沪深300非周期A(740101) |